Market Leadership GenMark Diagnostics is a recognized leader in multiplex molecular diagnostic solutions targeting infectious diseases, presenting opportunities to expand sales within hospitals, diagnostic labs, and healthcare providers seeking advanced testing capabilities.

Strong Acquisition Backing Having been acquired by Roche for 1.8 billion dollars, GenMark benefits from an extensive distribution network and resources, enabling sales teams to leverage Roche's global presence to access new markets and accelerate product adoption.

Innovative Technology GenMark's cutting-edge ePlex platform and broad test menu position it well to meet increasing demand for fast, accurate diagnostic solutions, particularly for respiratory, bloodstream, and gastrointestinal infections, opening avenues for upselling and new customer acquisition.

Growing Revenue Potential With annual revenues between 50 and 100 million dollars and ongoing growth initiatives, there are significant opportunities to target healthcare facilities investing in molecular diagnostics to enhance clinical outcomes and operational efficiency.

Strategic Collaborations Partnerships with major healthcare companies like Roche provide a platform for collaborative sales efforts, joint marketing, and co-branding initiatives, making it easier to penetrate competitive markets and secure larger purchase agreements.